Allan Junge Hyldal

Investor | Board Member | Strategic Advisor | Operator

📍 Denmark🔄 Updated October 2026💼 5 investments📅 2 years investing🗓 Last invested Jun 2026
Angel investor🌍 DenmarkInvested this year
5
Total investments
2
Early stage
1
Mid stage
1
Late stage
2y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jun 2026
IMP combines advanced digital sensor technology with AI-driven signal analysis to continuously track key early warning scores biomarkers from a single non-invasive wearable. Engineered for continuous 24/7 deployment in acute wards, emergency departments, and post-operative care - and equally suited to hospital-at-home and elder-care monitoring. IMP ships with its own low-energy, secure wireless transmission setup - no reliance on hospital Wi-Fi, no complex IT integration, and no infrastructure upgrades need. MDR 2017/745 (Class IIb) approved and ISO 13485 certified.
Angel Investor
Oct 2025
From intermittent to continuous tracking lactate data Are you or someone you know doing everything in your power to reach the top of the podium someday? If so, NDURE wearable lactate sensor will help you those crucial steps closer to becoming the best. Inspired by the practices of some of sports biggest champions, we fundamentally believe that our continuous lactate tracker will revolutionize the sports industry and unlock human performance. Lactate tracking has recently become the most recognized metric for performance across different sports and athletes have started to integrate this into their training practices in order to gain those infamous "marginal gains". NDUREs continuous lactate biosensor enables sports athletes and their teams to gain continuous and real-time data of lactate levels in a convenient and efficient way. Our mission, thus, addresses all key areas in performance-improvement ranging from optimized recovery to enhanced stamina as we strive to help athletes and coaches optimize training planning. #sport #sporttech #startup #lifescience
Angel Investor
Jun 2025
Using cutting edge engineering to improve non-surgical care for patients.
Angel Investor
Nov 2024
PERFI Technologies is pioneering a breakthrough in 3D printing with volumetric additive manufacturing (VAM). This revolutionary technology reduces the production time of personalized objects from hours to minutes, transforming the possibilities for rapid, in-store manufacturing. PERFI’s initial focus is on B2B solutions for instant production of personalized earmolds for hearing aids, hearing protection and communication.
early stageManufacturing
Angel Investor
Jul 2024
We are on a mission to help women suffering from stress urinary incontinence. We have developed a groundbreaking solution to address this global issue. Our unique product, Obtinu®, is a patented and clinically proven medical device designed to provide effective assistance to women experiencing stress urinary incontinence. This innovative solution offers a safe, efficient, and simple way to regain continence and reclaim an active lifestyle. With more incontinence pads sold than diapers, the need for a solution like Obtinu® has never been more evident. Join us as we lead the way in empowering women and revolutionizing the approach to stress urinary incontinence.
Experience · 5 entries
All (5)
Investments (5)
2026
Angel Investor
Jun 2026
IMP combines advanced digital sensor technology with AI-driven signal analysis to continuously track key early warning scores biomarkers from a single non-invasive wearable. Engineered for continuous 24/7 deployment in acute wards, emergency departments, and post-operative care - and equally suited to hospital-at-home and elder-care monitoring. IMP ships with its own low-energy, secure wireless transmission setup - no reliance on hospital Wi-Fi, no complex IT integration, and no infrastructure upgrades need. MDR 2017/745 (Class IIb) approved and ISO 13485 certified.
2025
Angel Investor
Oct 2025
From intermittent to continuous tracking lactate data Are you or someone you know doing everything in your power to reach the top of the podium someday? If so, NDURE wearable lactate sensor will help you those crucial steps closer to becoming the best. Inspired by the practices of some of sports biggest champions, we fundamentally believe that our continuous lactate tracker will revolutionize the sports industry and unlock human performance. Lactate tracking has recently become the most recognized metric for performance across different sports and athletes have started to integrate this into their training practices in order to gain those infamous "marginal gains". NDUREs continuous lactate biosensor enables sports athletes and their teams to gain continuous and real-time data of lactate levels in a convenient and efficient way. Our mission, thus, addresses all key areas in performance-improvement ranging from optimized recovery to enhanced stamina as we strive to help athletes and coaches optimize training planning. #sport #sporttech #startup #lifescience
Angel Investor
Jun 2025
Using cutting edge engineering to improve non-surgical care for patients.
2024
Angel Investor
Nov 2024
PERFI Technologies is pioneering a breakthrough in 3D printing with volumetric additive manufacturing (VAM). This revolutionary technology reduces the production time of personalized objects from hours to minutes, transforming the possibilities for rapid, in-store manufacturing. PERFI’s initial focus is on B2B solutions for instant production of personalized earmolds for hearing aids, hearing protection and communication.
early stageManufacturing
Angel Investor
Jul 2024
We are on a mission to help women suffering from stress urinary incontinence. We have developed a groundbreaking solution to address this global issue. Our unique product, Obtinu®, is a patented and clinically proven medical device designed to provide effective assistance to women experiencing stress urinary incontinence. This innovative solution offers a safe, efficient, and simple way to regain continence and reclaim an active lifestyle. With more incontinence pads sold than diapers, the need for a solution like Obtinu® has never been more evident. Join us as we lead the way in empowering women and revolutionizing the approach to stress urinary incontinence.
Investment activity
2024–2026 · 5 investments
202422025220261
Recent (last 2 years)Earlier